UroGen Pharma Ltd (URGN) Insider Trading
- $541,408.92
- $9,891,398.35
- March 18, 2024
- Mark Schoenberg
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
March 18, 2024 | Insider | 12,000 | $14.05 | Sell | $168,600.00 | |
Jan. 31, 2024 | Insider | 3,789 | $15.74 | Sell | $59,638.86 | |
Jan. 31, 2024 | General Counsel | 4,993 | $15.74 | Sell | $78,589.82 | |
Aug. 31, 2023 | General Counsel | 3,800 | $18.01 | Sell | $68,438.00 | |
Jan. 31, 2023 | Insider | 1,900 | $10.12 | Sell | $19,228.00 | |
Jan. 31, 2023 | General Counsel | 1,636 | $10.12 | Sell | $16,556.32 | |
Oct. 31, 2022 | Insider | 258 | $11.85 | Sell | $3,057.30 | |
April 30, 2022 | Insider | 254 | $6.62 | Sell | $1,681.48 | |
Jan. 31, 2022 | CFO | 331 | $7.58 | Sell | $2,508.98 | |
Jan. 31, 2022 | Insider | 1,374 | $7.58 | Sell | $10,414.92 | |
Jan. 31, 2022 | General Counsel | 414 | $7.58 | Sell | $3,138.12 | |
Jan. 31, 2022 | CEO | 8,195 | $7.58 | Sell | $62,118.10 | |
Jan. 26, 2022 | Insider | 111 | $8.09 | Sell | $897.99 | |
Jan. 4, 2022 | CEO | 46,968 | $9.15 | Sell | $429,757.20 | |
Nov. 30, 2021 | CFO | 2,587 | $12.03 | Sell | $31,121.61 | |
Nov. 30, 2021 | General Counsel | 3,803 | $12.03 | Sell | $45,750.09 | |
Nov. 18, 2021 | Insider | 160 | $13.10 | Buy | $2,096.00 | |
Nov. 1, 2021 | Insider | 258 | $17.16 | Sell | $4,427.28 | |
Oct. 27, 2021 | Insider | 107 | $16.32 | Sell | $1,746.24 | |
Aug. 2, 2021 | Insider | 243 | $15.64 | Sell | $3,800.52 | |
July 26, 2021 | Insider | 103 | $15.30 | Sell | $1,575.90 | |
May 17, 2021 | CFO | 2,500 | $15.85 | Buy | $39,625.00 | |
April 26, 2021 | Insider | 89 | $19.63 | Sell | $1,747.07 | |
Jan. 31, 2021 | Insider | 1,076 | $22.07 | Sell | $23,747.32 | |
Jan. 26, 2021 | Insider | 100 | $22.12 | Sell | $2,212.00 | |
Dec. 14, 2020 | CEO | 10,000 | $18.50 | Buy | $185,000.00 | |
Dec. 4, 2020 | Insider | 662 | $19.85 | Sell | $13,140.70 | |
Oct. 26, 2020 | Insider | 101 | $20.95 | Sell | $2,115.95 | |
Oct. 15, 2020 | CFO | 2,400 | $21.77 | Sell | $52,248.00 | |
Sept. 4, 2020 | Insider | 348 | $20.20 | Sell | $7,029.60 | |
July 27, 2020 | Insider | 70 | $23.51 | Sell | $1,645.70 | |
July 27, 2020 | CFO | 141 | $23.51 | Sell | $3,314.91 | |
June 4, 2020 | Insider | 349 | $27.51 | Sell | $9,600.99 | |
April 27, 2020 | CFO | 141 | $24.35 | Sell | $3,433.35 | |
April 27, 2020 | Insider | 70 | $24.35 | Sell | $1,704.50 | |
April 27, 2020 | COO | 145 | $24.35 | Sell | $3,530.75 | |
Feb. 14, 2020 | COO | 612 | $28.04 | Sell | $17,160.48 | |
Jan. 27, 2020 | Insider | 322 | $29.15 | Sell | $9,386.30 | |
Jan. 27, 2020 | CFO | 667 | $29.28 | Sell | $19,529.76 | |
Jan. 27, 2020 | COO | 684 | $29.26 | Sell | $20,013.84 | |
Nov. 20, 2019 | CEO | 7,470 | $28.00 | Buy | $209,160.00 | |
Nov. 20, 2019 | CFO | 354 | $28.41 | Sell | $10,057.14 | |
Nov. 19, 2019 | Insider | 1,960 | $28.17 | Buy | $55,213.20 | |
Nov. 15, 2019 | CEO | 1,548 | $26.00 | Buy | $40,248.00 | |
Nov. 14, 2019 | COO | 608 | $26.00 | Sell | $15,808.00 | |
Aug. 20, 2019 | CFO | 1,416 | $33.07 | Sell | $46,827.12 | |
Aug. 15, 2019 | COO | 608 | $31.65 | Sell | $19,243.20 | |
May 14, 2019 | COO | 608 | $37.98 | Sell | $23,091.84 | |
March 21, 2019 | Insider | 272 | $37.01 | Buy | $10,066.72 | |
March 6, 2019 | Insider | 1,991 | $37.30 | Sell | $74,264.30 |
Insiders are both buying and selling UroGen Pharma Ltd stock.
The insider traders at UroGen Pharma Ltd are: Mark Schoenberg, Stephen Mullennix, Peter P Pfreundschuh, Jason Drew Smith, Elizabeth A Barrett, Molly Henderson, and Proquest Investments Iv, L.P.
The most active insider trader at UroGen Pharma Ltd is Mark Schoenberg with 25 trades.
Proquest Investments Iv, L.P. has sold the most UroGen Pharma Ltd stock with a total value of $16,994,997.60.
Elizabeth A Barrett has bought the most UroGen Pharma Ltd stock with a total value of $619,408.00.
The most recent insider trade for UroGen Pharma Ltd was on March 18, 2024.
The single biggest insider buy for UroGen Pharma Ltd was from Elizabeth A Barrett with a total value of $209,160.00 on Nov. 20, 2019.
The single biggest insider sell for UroGen Pharma Ltd was from Proquest Investments Iv, L.P. with a total value of $8,497,498.80 on Nov. 28, 2017.